Evidence map›Paper›PMID 41897612›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Plexiform Fibromyxoma with MALAT1-GLI1 Fusion with Limited Myxoid Stroma, Aberrant KIT Expression, and Diffuse D2-40 Expression: A Case Report.

Kotaro Watanabe, Kazuhito Tanaka, Kohei Ohkura, Kojiro Eto, Satoshi Ida, Kohei Yamashita, Yushi Kawakami, Keita Kai, Hidetaka Yamamoto, Yasuhito Tanaka and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kotaro WatanabeDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Kazuhito TanakaDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Kohei OhkuraDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Kojiro EtoDepartment of Gastroenterological Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Satoshi IdaDepartment of Gastroenterological Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Kohei YamashitaDepartment of Gastroenterological Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Yushi KawakamiDepartment of Gastroenterology and Hepatology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Keita KaiDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.ORCID 0000-0003-1553-2598
Hidetaka YamamotoDepartment of Pathology, Graduate School of Medicine, Dentistry & Pharmaceutical Science, Okayama University, Okayama 700-8558, Japan.
Yasuhito TanakaDepartment of Gastroenterology and Hepatology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.ORCID 0000-0002-2473-6966
Masaaki IwatsukiDepartment of Gastroenterological Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan.ORCID 0000-0002-0886-4618
Yoshiki MikamiDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto 860-8556, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

D2-40MALAT1-GLI1 fusionplexiform fibromyxomastomachvariant morphology

Identifiers

PMID41897612
PMCPMC13025454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.